112 related articles for article (PubMed ID: 9257058)
1. HMG-CoA reductase inhibitor suppression of glomerular cell proliferation in rats with anti-Thy-1.1 nephritis.
Nabeshima K; Inui K; Uda S; Sugenoya Y; Iwasaki S; Ideura T; Yoshimura A
Contrib Nephrol; 1997; 120():153-9. PubMed ID: 9257058
[No Abstract] [Full Text] [Related]
2. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
Yoshimura A; Inui K; Nemoto T; Uda S; Sugenoya Y; Watanabe S; Yokota N; Taira T; Iwasaki S; Ideura T
J Am Soc Nephrol; 1998 Nov; 9(11):2027-39. PubMed ID: 9808088
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin inhibits the cellular signaling and proliferative action of arginine vasopressin in cultured rat glomerular mesangial cells.
Ishikawa S; Kawasumi M; Saito T
Endocrinology; 1995 May; 136(5):1954-61. PubMed ID: 7720643
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of statins on fetal bovine serum-induced proliferation of rat cultured mesangial cells and correlation between their inhibitory effect and transport characteristics.
Nagasawa K; Muraki Y; Matsuda T; Ohnishi N; Yokoyama T
J Pharm Sci; 2000 Dec; 89(12):1594-604. PubMed ID: 11042608
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types.
Nègre-Aminou P; van Vliet AK; van Erck M; van Thiel GC; van Leeuwen RE; Cohen LH
Biochim Biophys Acta; 1997 Apr; 1345(3):259-68. PubMed ID: 9150246
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
Alberts AW
Cardiology; 1990; 77 Suppl 4():14-21. PubMed ID: 2073667
[TBL] [Abstract][Full Text] [Related]
8. Extracellular actin impairs glomerular capillary repair in experimental mesangioproliferative glomerulonephritis.
Janssen U; Eitner F; Kunter U; Ostendorf T; Wolf G; Chaponnier C; Gabbiani G; Kerjaschki D; Floege J
Nephron Exp Nephrol; 2003; 93(4):e158-67. PubMed ID: 12759577
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin inhibits PDGF-induced DNA synthesis in human glomerular mesangial cells.
Grandaliano G; Biswas P; Choudhury GG; Abboud HE
Kidney Int; 1993 Sep; 44(3):503-8. PubMed ID: 8231022
[TBL] [Abstract][Full Text] [Related]
10. Local actions of endogenous angiotensin II in injured glomeruli.
Ma J; Matsusaka T; Yang H; Kawachi H; Shimizu F; Isaka Y; Imai E; Kon V; Ichikawa I
J Am Soc Nephrol; 2004 May; 15(5):1268-76. PubMed ID: 15100367
[TBL] [Abstract][Full Text] [Related]
11. Effects of HMG-CoA reductase inhibitors on growth and differentiation of cultured rat skeletal muscle cells.
Veerkamp JH; Smit JW; Benders AA; Oosterhof A
Biochim Biophys Acta; 1996 Apr; 1315(3):217-22. PubMed ID: 8611662
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors.
Saheki A; Terasaki T; Tamai I; Tsuji A
Pharm Res; 1994 Feb; 11(2):305-11. PubMed ID: 8165193
[TBL] [Abstract][Full Text] [Related]
13. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
[TBL] [Abstract][Full Text] [Related]
14. Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells.
Oi S; Haneda T; Osaki J; Kashiwagi Y; Nakamura Y; Kawabe J; Kikuchi K
Eur J Pharmacol; 1999 Jul; 376(1-2):139-48. PubMed ID: 10440099
[TBL] [Abstract][Full Text] [Related]
15. Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats.
Chen YM; Hu-Tsai MI; Lin SL; Tsai TJ; Hsieh BS
Nephrol Dial Transplant; 2003 Dec; 18(12):2505-14. PubMed ID: 14605272
[TBL] [Abstract][Full Text] [Related]
16. Source of reactive oxygen species in anti-Thy1 nephritis.
Nakamura K; Oka M; Shirai M; Igarashi Y; Kojima K; Kaneko O; Hamada N; Mera J; Masaoka H; Nagase M
Ren Fail; 1998 Mar; 20(2):399-405. PubMed ID: 9574468
[TBL] [Abstract][Full Text] [Related]
17. Regulation of mesangial cell proliferation by the mevalonate pathway.
Massy ZA; Guijarro C; O'Donnell MP; Kasiske BL; Keane WF
Contrib Nephrol; 1997; 120():191-6. PubMed ID: 9257061
[No Abstract] [Full Text] [Related]
18. Differences in the effects of HMG-CoA reductase inhibitors on proliferation and viability of smooth muscle cells in culture.
Sindermann JR; Fan L; Weigel KA; Troyer D; Müller JG; Schmidt A; March KL; Breithardt G
Atherosclerosis; 2000 Jun; 150(2):331-41. PubMed ID: 10856525
[TBL] [Abstract][Full Text] [Related]
19. Effects of lipids on the pathogenesis of progressive renal failure: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the prevention of glomerulosclerosis.
Guijarro C; Keane WF
Miner Electrolyte Metab; 1996; 22(1-3):147-52. PubMed ID: 8676808
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis.
Stahl RA; Thaiss F; Disser M; Helmchen U; Hora K; Schlöndorff D
Kidney Int; 1993 Nov; 44(5):1036-47. PubMed ID: 8264133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
